Olon Spa, based in Italy, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is RIFABUTIN, with a corresponding US DMF Number 29047.
Remarkably, this DMF maintains an Active status since its submission on January 22, 2015, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of July 20, 2018, and payment made on May 08, 2018, indicating their dedication to facilitating drug approvals, Categorized as Type II